.
Name : Ms. SUNITA GUPTA
Lab No. : 176483662 Age : 56 Years
Ref By : DR S K PANDITA Gender : Female
Collected : 15/4/2024 7:35:00AM Reported : 15/4/2024 7:18:26PM
A/c Status : P Report Status : Final
Collected at : FPSC RAJNAGAR EXT.II-GHAZIABAD Processed at : LPL-GHAZIABAD
SHOP 01,CLASSIC ARCADE,CLASSIC C-30, BEHIND HDFC BANK, RDC, Raj Nagar,
RESIDENCY RAJANAGAR EXTENSION Ghaziabad-201002
GHAZIABAD-201001
GHAZIABAD
Test Report
Test Name Results Units Bio. Ref. Interval
HEMOGRAM
(Photometry, Electrical Impedance, Vcs Technology & Calculated, capillary photometry)
Hemoglobin 10.80 g/dL 12.00 - 15.00
Packed Cell Volume (PCV) 34.20 % 36.00 - 46.00
RBC Count 3.82 mill/mm3 3.80 - 4.80
MCV 89.30 fL 83.00 - 101.00
MCH 28.20 pg 27.00 - 32.00
MCHC 31.60 g/dL 31.50 - 34.50
Red Cell Distribution Width (RDW) 16.10 % 11.60 - 14.00
Total Leukocyte Count (TLC) 25.10 thou/mm3 4.00 - 10.00
Differential Leucocyte Count (DLC)
Segmented Neutrophils 86.40 % 40.00 - 80.00
Lymphocytes 7.10 % 20.00 - 40.00
Monocytes 5.70 % 2.00 - 10.00
Eosinophils 0.50 % 1.00 - 6.00
Basophils 0.30 % <2.00
Absolute Leucocyte Count
Neutrophils 21.69 thou/mm3 2.00 - 7.00
Lymphocytes 1.78 thou/mm3 1.00 - 3.00
Monocytes 1.43 thou/mm3 0.20 - 1.00
Eosinophils 0.13 thou/mm3 0.02 - 0.50
Basophils 0.08 thou/mm3 0.02 - 0.10
Platelet Count 418 thou/mm3 150.00 - 410.00
Mean Platelet Volume 9.6 fL 6.5 - 12.0
E.S.R. 67 mm/hr 0 - 20
*176483662* Page 1 of 6
.
Name : Ms. SUNITA GUPTA
Lab No. : 176483662 Age : 56 Years
Ref By : DR S K PANDITA Gender : Female
Collected : 15/4/2024 7:35:00AM Reported : 15/4/2024 7:18:26PM
A/c Status : P Report Status : Final
Collected at : FPSC RAJNAGAR EXT.II-GHAZIABAD Processed at : LPL-GHAZIABAD
SHOP 01,CLASSIC ARCADE,CLASSIC C-30, BEHIND HDFC BANK, RDC, Raj Nagar,
RESIDENCY RAJANAGAR EXTENSION Ghaziabad-201002
GHAZIABAD-201001
GHAZIABAD
Test Report
Test Name Results Units Bio. Ref. Interval
Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood
*176483662* Page 2 of 6
.
Name : Ms. SUNITA GUPTA
Lab No. : 176483662 Age : 56 Years
Ref By : DR S K PANDITA Gender : Female
Collected : 15/4/2024 7:35:00AM Reported : 15/4/2024 7:18:26PM
A/c Status : P Report Status : Final
Collected at : FPSC RAJNAGAR EXT.II-GHAZIABAD Processed at : LPL-GHAZIABAD
SHOP 01,CLASSIC ARCADE,CLASSIC C-30, BEHIND HDFC BANK, RDC, Raj
RESIDENCY RAJANAGAR EXTENSION Nagar, Ghaziabad-201002
GHAZIABAD-201001
GHAZIABAD
Test Report
Test Name Results Units Bio. Ref. Interval
LIVER PANEL 1; LFT,SERUM
AST (SGOT) 22.5 U/L <35
(IFCC without P5P)
ALT (SGPT) 29.1 U/L <35
(IFCC without P5P)
AST:ALT Ratio 0.77 <1.00
(Calculated)
GGTP 92.1 U/L <38
(IFCC)
Alkaline Phosphatase (ALP) 216.20 U/L 30 - 120
(IFCC, AMP BUFFER)
Bilirubin Total 1.20 mg/dL 0.30 - 1.20
(DPD)
Bilirubin Direct 0.48 mg/dL <0.2
(DPD)
Bilirubin Indirect 0.72 mg/dL <1.10
(Calculated)
Total Protein 5.85 g/dL 6.40 - 8.30
(Biuret)
Albumin 2.60 g/dL 3.50 - 5.20
(BCG)
A : G Ratio 0.80 0.90 - 2.00
(Calculated)
Note
1. In an asymptomatic patient, Non alcoholic fatty liver disease (NAFLD) is the most common cause of
increased AST, ALT levels. NAFLD is considered as hepatic manifestation of metabolic syndrome.
2. In most type of liver disease, ALT activity is higher than that of AST; exception may be seen in Alcoholic
Hepatitis, Hepatic Cirrhosis, and Liver neoplasia. In a patient with Chronic liver disease, AST:ALT
ratio>1 is highly suggestive of advanced liver fibrosis.
3. In known cases of Chronic Liver disease due to Viral Hepatitis B & C, Alcoholic liver disease or NAFLD,
Enhanced liver fibrosis (ELF) test may be used to evaluate liver fibrosis.
4. In a patient with Chronic Liver disease, AFP and Des-gamma carboxyprothrombin (DCP)/PIVKA II can
be used to assess risk for development of Hepatocellular Carcinoma.
*176483662* Page 3 of 6
.
Name : Ms. SUNITA GUPTA
Lab No. : 176483662 Age : 56 Years
Ref By : DR S K PANDITA Gender : Female
Collected : 15/4/2024 7:35:00AM Reported : 15/4/2024 7:18:26PM
A/c Status : P Report Status : Final
Collected at : FPSC RAJNAGAR EXT.II-GHAZIABAD Processed at : LPL-GHAZIABAD
SHOP 01,CLASSIC ARCADE,CLASSIC C-30, BEHIND HDFC BANK, RDC, Raj
RESIDENCY RAJANAGAR EXTENSION Nagar, Ghaziabad-201002
GHAZIABAD-201001
GHAZIABAD
Test Report
Test Name Results Units Bio. Ref. Interval
HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP certified)
HbA1c 6.5 % 4.00 - 5.60
Estimated average glucose (eAG) 140 mg/dL
Interpretation
HbA1c result is suggestive of Diabetes/ well controlled Diabetes in a known Diabetic
Interpretation as per American Diabetes Association (ADA) Guidelines
------------------------------------------------------------------------------------------
| Reference Group | Non diabetic | At risk | Diagnosing | Therapeutic goals |
| | adults >=18 years | (Prediabetes) | Diabetes | for glycemic control |
| ----------------|-------------------|---------------|-------------|----------------------|
| HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0 |
------------------------------------------------------------------------------------------
Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.
---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |
| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |
---------------------------------------------------------------------------------
Dr Swati Singh
MD, Pathology
Chief of Laboratory
Dr Lal PathLabs Ltd
*176483662* Page 4 of 6
.
Name : Ms. SUNITA GUPTA
Lab No. : 176483662 Age : 56 Years
Ref By : DR S K PANDITA Gender : Female
Collected : 15/4/2024 7:35:00AM Reported : 15/4/2024 7:18:26PM
A/c Status : P Report Status : Final
Collected at : FPSC RAJNAGAR EXT.II-GHAZIABAD Processed at : LPL-PREET VIHAR
SHOP 01,CLASSIC ARCADE,CLASSIC Plot no. 33, Defence Enclave, Vikas Marg,
RESIDENCY RAJANAGAR EXTENSION Preet Vihar, New Delhi-110092
GHAZIABAD-201001
GHAZIABAD
Test Report
Test Name Results Units Bio. Ref. Interval
PROCALCITONIN (PCT), SERUM 0.53 ng/mL <0.5
(CLIA)
Interpretation
----------------------------------------------------------------------
|REFERENCE RANGE in ng/ml | COMMENTS |
|---------------------------|------------------------------------------|
|<0.50 | Low risk of severe sepsis/Septic shock |
|---------------------------|------------------------------------------|
|0.50-2.00 | Borderline risk |
|---------------------------|------------------------------------------|
|>2.00 | High risk of severe sepsis/Septic Shock |
----------------------------------------------------------------------
Note : For diagnostic purpose,the result should always be interpreted in conjunction with patient ’s medical
history as several non-infectious causes can also elevate Procalcitonin levels
Comments
Procalcitonin (PCT) is a prohormone expressed by neuroendocrine cells (C cells of thyroid,
pulmonary and pancreatic tissues) present in very low levels in healthy individuals. Measurement of
PCT can be used as a marker of severe sepsis and generally grades well with the degree of sepsis .
Evidence is emerging that PCT levels can reduce unnecessary antibiotic prescribing in lower
respiratory tract infections.
Increased Levels
· Infectious - Bacterial infections leading to Septic shock/Severe sepsis, Community acquired
respiratory tract infections & Ventilator induced pneumonia
· Non Infectious - Severe Cardiogenic shock, organ perfusion anomalies, Small cell lung cancer
or Medullary C-cell carcinoma of thyroid, major trauma, surgical intervention & severe burns,
treatment which stimulate the release of pro-inflammatory cytokines & Neonates (<48 hrs. after
birth)
Clinical Use
· As a prognostic marker to support outcome prediction in sepsis patients.
· As an indicator of severity and major complications in acute pancreatitis.
· As a guide for the necessity of antibiotic therapy and to monitor success of treatments in patients
suffering from community-acquired respiratory tract infections or ventilator-induced pneumonia.
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
*176483662*
Page 5 of 6
.
Name : Ms. SUNITA GUPTA
Lab No. : 176483662 Age : 56 Years
Ref By : DR S K PANDITA Gender : Female
Collected : 15/4/2024 7:35:00AM Reported : 15/4/2024 7:18:26PM
A/c Status : P Report Status : Final
Collected at : FPSC RAJNAGAR EXT.II-GHAZIABAD Processed at : LPL-PREET VIHAR
SHOP 01,CLASSIC ARCADE,CLASSIC Plot no. 33, Defence Enclave, Vikas Marg,
RESIDENCY RAJANAGAR EXTENSION Preet Vihar, New Delhi-110092
GHAZIABAD-201001
GHAZIABAD
Test Report
Test Name Results Units Bio. Ref. Interval
Dr Gaurav Jyoti Phukan Dr.Sneha Kumari
DCP, Pathology
Chief of Laboratory Consultant Pathologist
Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
-------------------------------End of report --------------------------------
AHEEEHAPMKHIEKENLGHBJJNCBILLJCECCIJCIKPLNKEDFEFAPPAHEEEHA
BNFFFNBPAPBOEKFGFGEHJOAPAOAHFHALAGJOBCJCNLELNOJGMPBNFFFNB
GMDAFBFNNOMIEHKNHFIAAJHFJEHEHEDDNKPHENFLMKLMOEFLBKGDEHANP
DJDCMMFNBDHIELEOPKOELEPFANPLAKAFJIFFPAPAKKNJPDNLIJFBKEMEL
JCLKJLFIOJJFDIAELPIGMHBCDENNONCHKKMHGEEIPLKGKPNGKFFFOOKJC
EKCBBEFCPECAMKHKIMNMIIPBADHFOFAINDFCBKDLBLIKOMNALNEIOGMKD
LBIMIJFJELOMDLLIEOIHLGGHIHAFJBAKPLMPBLMMKJCHKNFMIJNJIDILD
BNFNAMFMAKPCKEKMAANHDPGILLBMFMBBKFCCAMNNIJKDKPNGBNFMAHILL
NKEAPMFNFAGGFEIMGMMIHJJKHEAFEKFBJFFKBLPFOEBIOCNKDJPHNEKLJ
OMNFIDFCELMJJDCFPKAOIDJJBDFKPNJHKEPDGNNLNKCKIGEOCMHKHOCIK
NBIKNMFLGKKKNNBMPEMBMJEEINMPPAFBJMEEBFOFPNDMKPFKEPCIGCIEO
ICICGJFMMLDPILNMHPCABMDEIEOPPFOEACNPBLNOOLJAIANINKONHDICL
MNNNNNEHCECEEKMAGCFLHFBHJBAHFHAFPKPFCMNLMKJIPFNIAHFHAHIKL
APBBBPAPBJKAEBFKFNAKCMIFAHECHHCAONFFPLOGOLMHNLNNEDFDDBKHH
HHHHHHHPHHPPHPPPHPPPPHPHHHPPPPPPPPPHHHPPPHHHPHPHHHHPPHPHP
IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost for
derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe Courts/Forum
at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid for medico legal
purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical Practitioner /Doctor.ŸThe report does
not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: [email protected]
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
*176483662*
Page 6 of 6
